Literature DB >> 28693365

Behavior of Xeno-Transplanted Undifferentiated Human Induced Pluripotent Stem Cells Is Impacted by Microenvironment Without Evidence of Tumors.

Veronica Martínez-Cerdeño1,2,3, Bonnie L Barrilleaux2,3,4, Ashley McDonough3, Jeanelle Ariza3, Benjamin T K Yuen2,3,4, Priyanka Somanath2,3,4, Catherine T Le2,3,4, Craig Steward3, Kayla Horton-Sparks3, Paul S Knoepfler2,3,4.   

Abstract

Human pluripotent stem cells (hPSC) have great clinical potential through the use of their differentiated progeny, a population in which there is some concern over risks of tumorigenicity or other unwanted cellular behavior due to residual hPSC. Preclinical studies using human stem cells are most often performed within a xenotransplant context. In this study, we sought to measure how undifferentiated hPSC behave following xenotransplant. We directly transplanted undifferentiated human induced pluripotent stem cells (hIPSC) and human embryonic stem cells (hESC) into the adult mouse brain ventricle and analyzed their fates. No tumors or precancerous lesions were present at more than one year after transplantation. This result differed with the tumorigenic capacity we observed after allotransplantation of mouse ESC into the mouse brain. A substantial population of cellular derivatives of undifferentiated hESC and hIPSC engrafted, survived, and migrated within the mouse brain parenchyma. Within brain structures, transplanted cell distribution followed a very specific pattern, suggesting the existence of distinct microenvironments that offer different degrees of permissibility for engraftment. Most of the transplanted hESC and hIPSC that developed into brain cells were NeuN+ neuronal cells, and no astrocytes were detected. Substantial cell and nuclear fusion occurred between host and transplanted cells, a phenomenon influenced by microenvironment. Overall, hIPSC appear to be largely functionally equivalent to hESC in vivo. Altogether, these data bring new insights into the behavior of stem cells without prior differentiation following xenotransplantation into the adult brain.

Entities:  

Keywords:  cell fate; microenvironment; teratoma; tumorigenesis

Mesh:

Year:  2017        PMID: 28693365      PMCID: PMC5647528          DOI: 10.1089/scd.2017.0059

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  62 in total

1.  A call to standardize teratoma assays used to define human pluripotent cell lines.

Authors:  Franz-Josef Müller; Johanna Goldmann; Peter Löser; Jeanne F Loring
Journal:  Cell Stem Cell       Date:  2010-05-07       Impact factor: 24.633

2.  Spontaneous fusion with, and transformation of mouse stroma by, malignant human breast cancer epithelium.

Authors:  Britta M Jacobsen; J Chuck Harrell; Paul Jedlicka; Virginia F Borges; Marileila Varella-Garcia; Kathryn B Horwitz
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

3.  Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.

Authors:  Michiko Mandai; Akira Watanabe; Yasuo Kurimoto; Yasuhiko Hirami; Chikako Morinaga; Takashi Daimon; Masashi Fujihara; Hiroshi Akimaru; Noriko Sakai; Yumiko Shibata; Motoki Terada; Yui Nomiya; Shigeki Tanishima; Masahiro Nakamura; Hiroyuki Kamao; Sunao Sugita; Akishi Onishi; Tomoko Ito; Kanako Fujita; Shin Kawamata; Masahiro J Go; Chikara Shinohara; Ken-Ichiro Hata; Masanori Sawada; Midori Yamamoto; Sachiko Ohta; Yasuo Ohara; Kenichi Yoshida; Junko Kuwahara; Yuko Kitano; Naoki Amano; Masafumi Umekage; Fumiyo Kitaoka; Azusa Tanaka; Chihiro Okada; Naoko Takasu; Seishi Ogawa; Shinya Yamanaka; Masayo Takahashi
Journal:  N Engl J Med       Date:  2017-03-16       Impact factor: 91.245

4.  Long-term fate of neural precursor cells following transplantation into developing and adult CNS.

Authors:  A C Lepore; B Neuhuber; T M Connors; S S W Han; Y Liu; M P Daniels; M S Rao; I Fischer
Journal:  Neuroscience       Date:  2006-02-03       Impact factor: 3.590

5.  Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency.

Authors:  Frederick Anokye-Danso; Chinmay M Trivedi; Denise Juhr; Mudit Gupta; Zheng Cui; Ying Tian; Yuzhen Zhang; Wenli Yang; Peter J Gruber; Jonathan A Epstein; Edward E Morrisey
Journal:  Cell Stem Cell       Date:  2011-04-08       Impact factor: 24.633

6.  Human embryonic stem cells are prone to generate primitive, undifferentiated tumors in engrafted human fetal tissues in severe combined immunodeficient mice.

Authors:  Chu-Chih Shih; Stephen J Forman; Peiguo Chu; Marilyn Slovak
Journal:  Stem Cells Dev       Date:  2007-12       Impact factor: 3.272

7.  Survival and differentiation of adenovirus-generated induced pluripotent stem cells transplanted into the rat striatum.

Authors:  Kyle D Fink; Julien Rossignol; Ming Lu; Xavier Lévêque; Travis D Hulse; Andrew T Crane; Veronique Nerriere-Daguin; Robert D Wyse; Phillip A Starski; Matthew T Schloop; Dylan J Dues; Steve J Witte; Cheng Song; Ludovic Vallier; Tuan H Nguyen; Philippe Naveilhan; Ignacio Anegon; Laurent Lescaudron; Gary L Dunbar
Journal:  Cell Transplant       Date:  2013-07-22       Impact factor: 4.064

8.  Effects of human neural stem cell transplantation in canine spinal cord hemisection.

Authors:  Seung-Hoon Lee; You-Nam Chung; Yoon-Ha Kim; Young-Ju Kim; Jong-Pil Park; Dae-Kee Kwon; Oh-Seo Kwon; Jae-Hyeok Heo; Yoon-Hee Kim; Sun Ryu; Hyo-Jin Kang; Sun Ha Paek; Kyu-Chang Wang; Seung U Kim; Byung-Woo Yoon
Journal:  Neurol Res       Date:  2009-01-09       Impact factor: 2.448

9.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

10.  Somatic coding mutations in human induced pluripotent stem cells.

Authors:  Athurva Gore; Zhe Li; Ho-Lim Fung; Jessica E Young; Suneet Agarwal; Jessica Antosiewicz-Bourget; Isabel Canto; Alessandra Giorgetti; Mason A Israel; Evangelos Kiskinis; Je-Hyuk Lee; Yuin-Han Loh; Philip D Manos; Nuria Montserrat; Athanasia D Panopoulos; Sergio Ruiz; Melissa L Wilbert; Junying Yu; Ewen F Kirkness; Juan Carlos Izpisua Belmonte; Derrick J Rossi; James A Thomson; Kevin Eggan; George Q Daley; Lawrence S B Goldstein; Kun Zhang
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

View more
  3 in total

1.  ERBB3-Binding Protein 1 (EBP1) Is a Novel Developmental Pluripotency-Associated-4 (DPPA4) Cofactor in Human Pluripotent Cells.

Authors:  Priyanka Somanath; Kelly M Bush; Paul S Knoepfler
Journal:  Stem Cells       Date:  2018-01-29       Impact factor: 6.277

2.  Why use pre-differentiated cells to address complex multi-factorial neurodegenerative diseases?

Authors:  Alex Kopyov; Toni L Uhlendorf; Randy W Cohen
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

3.  Transplantation of Human Neural Progenitor Cells (NPC) into Putamina of Parkinsonian Patients: A Case Series Study, Safety and Efficacy Four Years after Surgery.

Authors:  I Madrazo; O Kopyov; M A Ávila-Rodríguez; F Ostrosky; H Carrasco; A Kopyov; A Avendaño-Estrada; F Jiménez; E Magallón; C Zamorano; G González; T Valenzuela; R Carrillo; F Palma; R Rivera; R E Franco-Bourland; G Guízar-Sahagún
Journal:  Cell Transplant       Date:  2018-12-21       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.